Cara Therapeutics, Inc.
CARA
CARA: Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
moreShow CARA Financials
Recent trades of CARA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CARA's directors and management
Government lobbying spending instances
-
$10,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$10,000 Apr 20, 2023 Issue: Medicare/Medicaid
-
$12,000 Jul 20, 2022 Issue: Medicare/Medicaid
-
$15,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$16,000 Feb 09, 2022 Issue: Medicare/Medicaid
-
$12,500 Oct 20, 2021 Issue: Medicare/Medicaid
-
$23,750 Jul 21, 2021 Issue: Medicare/Medicaid
-
$9,500 Apr 20, 2021 Issue: Medicare/Medicaid
-
$9,000 Oct 19, 2020 Issue: Medicare/Medicaid
-
$7,000 Jul 20, 2020 Issue: Medicare/Medicaid
-
$7,000 Apr 20, 2020 Issue: Medicare/Medicaid
-
$13,000 Oct 26, 2019 Issue: Medicare/Medicaid
-
$5,000 Jul 26, 2019 Issue: Medicare/Medicaid
-
$20,000 Apr 19, 2019 Issue: Medicare/Medicaid
-
$12,000 Jan 22, 2019 Issue: Medicare/Medicaid
-
$15,000 Oct 22, 2018 Issue: Medicare/Medicaid
New patents grants
-
Patent Title: Oral formulations of kappa opioid receptor agonists Jun. 27, 2023
-
Patent Title: Oral formulations of kappa opioid receptor agonists Jun. 15, 2021
-
Patent Title: Synthetic peptide amides and dimers thereof Feb. 09, 2021
-
Patent Title: Synthetic peptide amides Oct. 06, 2020
-
Patent Title: Synthetic peptide amides Nov. 27, 2018
-
Patent Title: Synthetic peptide amides and dimers thereof Jul. 10, 2018
-
Patent Title: Synthetic peptide amides Jun. 07, 2016
-
Patent Title: Synthetic peptide amides and dimers thereof May. 10, 2016
-
Patent Title: Uses of kappa opioid synthetic peptide amides Apr. 26, 2016
-
Patent Title: Synthetic peptide amides for pain Feb. 10, 2015
-
Patent Title: Uses of substituted imidazoheterocycles Oct. 14, 2014
-
Patent Title: Substituted imidazoheterocycle derivatives Sep. 16, 2014
-
Patent Title: Methods for genetic analysis of textiles made of Mar. 11, 2014
-
Patent Title: Bicyclic pyrazolo-heterocycles Feb. 18, 2014
-
Patent Title: Synthetic peptide amides and dimers thereof Sep. 17, 2013
-
Patent Title: Synthetic peptide amides and dimeric forms thereof Jul. 16, 2013
-
Patent Title: Substituted imidazoheterocycles Apr. 30, 2013
-
Patent Title: Uses of synthetic peptide amides Aug. 07, 2012
-
Patent Title: Synthetic peptide amides Jul. 10, 2012
-
Patent Title: Method for elevating prolactin in mammals Jul. 10, 2012
-
Patent Title: Bicyclic pyrazolo-heterocycles Jul. 03, 2012
-
Patent Title: Substituted pyridoxazines Jun. 14, 2011
-
Patent Title: Benzo-fused heterocycles Jun. 14, 2011
-
Patent Title: Synthetic peptide amide dimers Nov. 30, 2010
-
Patent Title: Bicyclic pyrazolo-heterocycles Jun. 22, 2010
-
Patent Title: Synthetic peptide amides Jun. 01, 2010
-
Patent Title: Synthetic peptide amides and dimeric forms thereof May. 11, 2010
Federal grants, loans, and purchases
Followers on CARA's company Twitter account
Number of mentions of CARA in WallStreetBets Daily Discussion
Recent insights relating to CARA
Recent picks made for CARA stock on CNBC
ETFs with the largest estimated holdings in CARA
Flights by private jets registered to CARA